Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 121
Filtrar
1.
Ultramicroscopy ; 111(7): 847-53, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20832172

RESUMEN

We refine two low-order structure factors of the skutterudite CoSb3 using convergent beam electron diffraction. The relatively large unit cell of this material causes the disks to overlap and introduces a series of challenges in the refinement procedure. These challenges and future work-arounds are discussed. The refined structure factors F200 and F600 are compared to X-ray diffraction and density functional calculated values, the latter calculated using two different functionals. Both relaxed and experimental lattice parameters are tested to explicitly highlight the impact of the lattice geometry and atomic position on the structure factors.


Asunto(s)
Antimonio/química , Cobalto/química , Cristalografía por Rayos X/métodos , Electrones , Microscopía Electrónica de Transmisión , Modelos Moleculares , Modelos Teóricos
3.
4.
Acta Crystallogr A ; 61(Pt 2): 223-30, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15724072

RESUMEN

Quantitative convergent-beam electron diffraction (QCBED) experiments allow absolute scale measurements of low-order structure factors with very high accuracy. In this paper, eight low-order structure factors for copper measured by QCBED have been combined with the higher-order gamma-ray structure factors in order to obtain a larger highly accurate experimental data set. The gamma-ray values were relativistically corrected and rescaled. The new data set was then used for studying the charge distribution in copper. Charge deformation maps have been produced and both a maximum-entropy and a multipole analysis have been applied to the data. The result is compared to density functional theory calculations. An almost spherical charge depletion is found around the atomic sites showing typical metal bonding in copper.

5.
Mol Biol Cell ; 12(4): 1147-60, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11294913

RESUMEN

Deletion of the yeast gene ACB1 encoding Acb1p, the yeast homologue of the acyl-CoA-binding protein (ACBP), resulted in a slower growing phenotype that adapted into a faster growing phenotype with a frequency >1:10(5). A conditional knockout strain (Y700pGAL1-ACB1) with the ACB1 gene under control of the GAL1 promoter exhibited an altered acyl-CoA profile with a threefold increase in the relative content of C18:0-CoA, without affecting total acyl-CoA level as previously reported for an adapted acb1Delta strain. Depletion of Acb1p did not affect the general phospholipid pattern, the rate of phospholipid synthesis, or the turnover of individual phospholipid classes, indicating that Acb1p is not required for general glycerolipid synthesis. In contrast, cells depleted for Acb1p showed a dramatically reduced content of C26:0 in total fatty acids and the sphingolipid synthesis was reduced by 50-70%. The reduced incorporation of [(3)H]myo-inositol into sphingolipids was due to a reduced incorporation into inositol-phosphoceramide and mannose-inositol-phosphoceramide only, a pattern that is characteristic for cells with aberrant endoplasmic reticulum to Golgi transport. The plasma membrane of the Acb1p-depleted strain contained increased levels of inositol-phosphoceramide and mannose-inositol-phosphoceramide and lysophospholipids. Acb1p-depleted cells accumulated 50- to 60-nm vesicles and autophagocytotic like bodies and showed strongly perturbed plasma membrane structures. The present results strongly suggest that Acb1p plays an important role in fatty acid elongation and membrane assembly and organization.


Asunto(s)
Proteínas Portadoras/fisiología , Proteínas Fúngicas/fisiología , Esfingolípidos/biosíntesis , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Membrana Celular , Inhibidor de la Unión a Diazepam , Ácidos Grasos/biosíntesis , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Fosfatidiletanolaminas/biosíntesis , Fosfatidilinositoles/biosíntesis , Fosfatidilserinas/biosíntesis , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/fisiología
6.
J Med Chem ; 42(20): 4140-9, 1999 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-10514284

RESUMEN

Development of resistance to currently approved HIV therapies has continued to fuel research efforts to improve the metabolic stability and spectrum of activity of the (alkylamino)piperidine-containing bis(heteroaryl)piperazine (AAP-BHAP) class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). The synthesis of analogues in which the usual 3-alkylamino substituent on the pyridine ring is replaced by a 3-alkyl substituent led to compounds which retained activity against recombinant P236L and wild-type (WT) reverse transcriptase (RT), while inhibition of the Y181C mutant RT was reduced relative to the activity of the 3-alkylamino-substituted congeners. Testing of representative analogues in an in vitro liver microsome assay indicated that the alkyl substituent would not appreciably improve the metabolic stability of the AAP-BHAP template. In vivo pharmacokinetic evaluation of three compounds confirmed these results in that high systemic clearances were observed. Nevertheless, one compound (13), PNU-103657, possessed oral bioavailability in rats approaching that of the structurally related NNRTI drug delavirdine which is currently on the market for the treatment of HIV infection.


Asunto(s)
Aminopiridinas/síntesis química , Fármacos Anti-VIH/síntesis química , Piperidinas/síntesis química , Inhibidores de la Transcriptasa Inversa/síntesis química , Sulfonamidas/síntesis química , Administración Oral , Aminopiridinas/química , Aminopiridinas/farmacocinética , Aminopiridinas/farmacología , Animales , Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacocinética , Fármacos Anti-VIH/farmacología , Disponibilidad Biológica , Células Cultivadas , Técnicas In Vitro , Inyecciones Intravenosas , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Piperidinas/química , Piperidinas/farmacología , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/antagonistas & inhibidores , Inhibidores de la Transcriptasa Inversa/química , Inhibidores de la Transcriptasa Inversa/farmacocinética , Inhibidores de la Transcriptasa Inversa/farmacología , Relación Estructura-Actividad , Sulfonamidas/química , Sulfonamidas/farmacocinética , Sulfonamidas/farmacología
7.
Ugeskr Laeger ; 161(24): 3650-4, 1999 Jun 14.
Artículo en Danés | MEDLINE | ID: mdl-10485222

RESUMEN

The aim of the present study was to examine the extent of secondary prophylaxis in patients following hospitalization under the diagnosis of ischaemic heart (IHD). Our data were based on hospital records and questionnaires sent to patients admitted to the Cardiological Department, Frederiksberg Hospital, under the diagnosis of IHD during the first six months of 1996. One hundred and twenty-five patients were included, of these 106 answered the questionnaire. We found that overall patients were insufficiently treated with aspirin, beta-blockers and antilipidaemic agents. Measures to reduce smoking and to increase physical exercise were sparse. We concluded that secondary intervention instituted from the Cardiological Department in question was not up to generally agreed standards. Suggestions to improve secondary prophylaxis in patients with IHD are presented. The importance of increased co-operation between hospital, general practitioner and patient is emphasized. A patient-born record designed for this purpose is presented.


Asunto(s)
Continuidad de la Atención al Paciente , Isquemia Miocárdica/prevención & control , Planificación de Atención al Paciente , Alta del Paciente , Adulto , Anciano , Angina de Pecho/tratamiento farmacológico , Angina de Pecho/prevención & control , Dinamarca , Femenino , Humanos , Masculino , Registros Médicos , Persona de Mediana Edad , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/prevención & control , Isquemia Miocárdica/tratamiento farmacológico , Factores de Riesgo , Encuestas y Cuestionarios
9.
Ugeskr Laeger ; 160(36): 5197-9, 1998 Aug 31.
Artículo en Danés | MEDLINE | ID: mdl-9741280

RESUMEN

This report is based on two case stories. Traumatic knee dislocation is a rare but serious event. There is extensive damage to the ligaments of the knee, but the vascular lesions, with an incidence of approximately 29% are of primary concern. Signs of ischaemia indicate arteriography or exploration, and if the vascular lesion is repaired within eight hours, the majority can avoid amputation. Complicating fractures, ligament lesions and nerve lesions have secondary priority to arterial lesions. A combination of surgical ligament-repair/reconstruction and intensive rehabilitation seems the most promising.


Asunto(s)
Luxaciones Articulares/diagnóstico por imagen , Traumatismos de la Rodilla/diagnóstico por imagen , Adulto , Humanos , Luxaciones Articulares/etiología , Luxaciones Articulares/rehabilitación , Luxaciones Articulares/cirugía , Traumatismos de la Rodilla/etiología , Traumatismos de la Rodilla/rehabilitación , Traumatismos de la Rodilla/cirugía , Masculino , Radiografía
11.
Cell Biol Int ; 22(9-10): 709-14, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10452842

RESUMEN

Saccharomyces cerevisiae was inoculated into a dilute synthetic minimal medium with glycerol as the carbon source. The number of live cells in the cultures was determined by colony counts on agar plates. Untreated control cells had doubled in number about once at the end of the first week and had gone through eight doublings by the end of the second week. Addition of either 8-bromo-cyclic guanosine monophosphate (8-bromo-cGMP) or human recombinant insulin, made the cells go through 12 and 10 doublings, respectively, by the end of the first week. In contrast, 8-bromo-cyclic adenosine monophosphate (8-bromo-cAMP) had only slight stimulating effects on cell multiplication, but if it was combined with phorbol-12-myristate-13-acetate (PMA) the cells went through about 12 doublings during the first week. Addition of LY 83583, an inhibitor of soluble guanylate cyclase, prevented cell proliferation. Further addition of 8-bromo-cGMP bypassed this inhibition. Singly, bradykinin or PMA did not affect cell multiplication. However, when these two compounds were combined, the cells went through about 10 doublings during the first week. Neither bradykinin, nor PMA had any releasing effect on the inhibition of LY 83583. These results indicate the existence of several routes leading to cell proliferation in wildtype S. cerevisiae cells.


Asunto(s)
Saccharomyces cerevisiae/citología , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Aminoquinolinas/farmacología , Bradiquinina/farmacología , División Celular/efectos de los fármacos , Medios de Cultivo , GMP Cíclico/análogos & derivados , GMP Cíclico/farmacología , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Guanilato Ciclasa/antagonistas & inhibidores , Humanos , Insulina/farmacología , Proteínas Recombinantes/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/fisiología , Transducción de Señal/fisiología , Acetato de Tetradecanoilforbol/farmacología
12.
J Med Chem ; 39(26): 5267-75, 1996 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-8978855

RESUMEN

The major route of metabolism of the bis(heteroaryl)piperazine (BHAP) class of reverse transcriptase inhibitors (RTIs), atevirdine and delavirdine, is via oxidative N-dealkylation of the 3-ethyl- or 3-isopropylamino substituent on the pyridine ring. This metabolic pathway is also the predominant mode of metabolism of (alkylamino)piperidine BHAP analogs (AAP-BHAPs), compounds wherein a 4-(alkylamino)piperidine replaces the piperazine ring of the BHAPs. The novel AAP-BHAPs possess the ability to inhibit non-nucleoside reverse transcriptase inhibitor (NNRTI) resistant recombinant HIV-1 RT and NNRTI resistant variants of HIV-1. This report describes an approach to preventing this degradation which involves the replacement of the 3-ethyl- or 3-isopropylamino substituent with either a 3-tert-butylamino substituent or a 3-alkoxy substituent. The synthesis, bioactivity and metabolic stability of these analogs is described. The majority of analogs retain inhibitory activities in enzyme and cell culture assays. In general, a 3-ethoxy or 3-isopropoxy substituent on the pyridine ring, as in compounds 10, 20, or 21, resulted in enhanced stabilities. The 3-tert-butylamino substituent was somewhat beneficial in the AAP-BHAP series of analogs, but did not exert a significant effect in the BHAP series. Lastly, the nature of the indole substitution sometimes plays a significant role in metabolic stability, particularly in the BHAP series of analogs.


Asunto(s)
Piperazinas/síntesis química , Piperazinas/farmacología , Inhibidores de la Transcriptasa Inversa/síntesis química , Inhibidores de la Transcriptasa Inversa/farmacología , Fármacos Anti-VIH/síntesis química , Fármacos Anti-VIH/metabolismo , Fármacos Anti-VIH/farmacología , Sistema Enzimático del Citocromo P-450/farmacología , VIH-1/enzimología , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Microsomas Hepáticos/enzimología , Piperazinas/metabolismo , Inhibidores de la Transcriptasa Inversa/metabolismo , Relación Estructura-Actividad
13.
J Med Chem ; 39(19): 3769-89, 1996 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-8809165

RESUMEN

A novel class of bis(heteroaryl)piperazine (BHAP) analogs which possesses the ability to inhibit NNRTI (non-nucleoside reverse transcriptase inhibitor) resistant recombinant HIV-1 reverse transcriptase (RT) and NNRTI resistant variants of HIV-1 has been identified via targeted screening. Further investigation of the structure-activity relationships of close congeners of these novel (alkylamino)piperidine BHAPs (AAP-BHAPs) led to the synthesis of several compounds possessing the desired phenotype (e.g., activity against recombinant RTs carrying the Y181C and P236L substitutions). Further structural modifications were required to inhibit metabolism and modulate solubility in order to obtain compounds with the desired biological profile as well as appropriate pharmaceutical properties. The AAP-BHAPs with the most suitable characteristics were compounds 7, 15, and 36.


Asunto(s)
Fármacos Anti-VIH/síntesis química , Farmacorresistencia Microbiana , VIH-1/efectos de los fármacos , Indoles/farmacología , Piperazinas/farmacología , Inhibidores de la Transcriptasa Inversa/síntesis química , Animales , Fármacos Anti-VIH/farmacocinética , Fármacos Anti-VIH/farmacología , Disponibilidad Biológica , Línea Celular , Delavirdina , Estabilidad de Medicamentos , Transcriptasa Inversa del VIH , Estructura Molecular , Piperidinas/síntesis química , Piperidinas/farmacocinética , Piperidinas/farmacología , Piridinas/síntesis química , Piridinas/farmacocinética , Piridinas/farmacología , Ratas , Inhibidores de la Transcriptasa Inversa/farmacocinética , Inhibidores de la Transcriptasa Inversa/farmacología , Relación Estructura-Actividad
14.
FEMS Microbiol Lett ; 132(1-2): 159-63, 1995 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-7590158

RESUMEN

Saccharomyces cerevisiae was inoculated into a yeast nitrogen base with either glycerol or glucose as carbon source. Cell proliferation was followed by colony counts on agar medium. Cells in the glycerol-supplemented medium divided less than once in 10 days. When glucose, 6-deoxy-glucose or protoporphyrin IX was added, the cells had doubling times of about 24 h and increased in number to about 0.5 x 10(6) cells ml-1. Addition of either of the protein kinase C activators oleoyl-acetyl-glycerol or phorbol-12-myristate-13-acetate did not activate cell proliferation in the glycerol medium. However, when (i) glucose was combined with either protoporphyrin IX or chlorophyllin, or (ii) either protoporphyrin IX or chlorophyllin was combined with either of the protein kinase C activators, the cells had doubling times of about 12 h. Hence, (i) glucose can act as both a carbon source and a signalling molecule for proliferation, and (ii) two systems are involved in activating cell proliferation in S. cerevisiae: one operating through a protein kinase C system and another through a guanylate cyclase system.


Asunto(s)
Glucosa/metabolismo , Proteína Quinasa C/metabolismo , Pirroles/metabolismo , Saccharomyces cerevisiae/crecimiento & desarrollo , División Celular , Recuento de Colonia Microbiana , Proteína Quinasa C/agonistas , Saccharomyces cerevisiae/metabolismo , Tetrapirroles , Factores de Tiempo
15.
J Chromatogr B Biomed Appl ; 668(1): 99-106, 1995 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-7550987

RESUMEN

A method for the determination of a bisheteroarylpiperazine, non-nucleoside HIV-1 reverse transcriptase inhibitor, delavirdine, and its N-desisopropyl metabolite in human plasma, is described. Samples were deproteinized by addition of two parts of a solution of internal standard in acetonitrile (1 microgram/ml) to one part plasma. The supernatant was diluted with 10 mM phosphate buffer, pH 6.0, and injected onto the HPLC system. Fluorescence of the eluent was monitored with excitation at 302 nm and emission at 425 nm. Quantitation of delavirdine and its metabolite was achieved by comparing the peak-height ratio of each component relative to the internal standard to a through-the-origin linear regression curve determined from fortified plasma calibration standards. The assay was linear over the concentration range 0.02-17 microM for both delavirdine and its metabolite. The precision of the method, as expressed by the mean C.V. of the back-calculated, non-zero, standard concentrations, was +/- 4.4% for delavirdine and +/- 4.3% for the metabolite. The assay has been validated and utilized to analyze samples from human and animal pharmacokinetic studies.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Indoles/sangre , Piperazinas/sangre , Artefactos , Delavirdina , VIH-1/enzimología , Humanos , Estándares de Referencia , Reproducibilidad de los Resultados , Inhibidores de la Transcriptasa Inversa , Espectrometría de Fluorescencia
18.
Acta Anaesthesiol Scand ; 38(8): 820-5, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7887105

RESUMEN

Platelets are activated in surgery releasing vasoactive substances such as serotonin and thromboxane. Platelets become temporarily hypoaggregable during surgery followed by a postoperative hyperaggregability. Local anaesthetics are known to inhibit platelet function but earlier reports are conflicting. In order to study the impact of the combined use of general and regional anaesthesia on platelet function during major surgery 16 otherwise healthy patients were randomised to either general anaesthesia (GA) (n = 8) or GA combined with epidural anaesthesia (GA+EPI) (n = 8) for elective upper abdominal surgery. Cyclic 3',5' adenosine monophosphate, plasma glucose, plasma cortisol and the rate pressure product (RPP) were markers of the stress response. ADP-induced platelet aggregation and the release products beta-thromboglobulin, serotonin and thromboxane 2 were measured in plasma before and during as well as for 3 days after surgery. A marked stress response was noted in both groups and epidural anaesthesia (EPI) only reduced the rate pressure product (RPP). Platelet aggregation was reduced during surgery, a little more so in the GA+EPI group. Postoperatively both groups showed significant hyperaggregability. The release products were not significantly influenced by regional anaesthesia. In conclusion epidural as combined with general anaesthesia affects platelet responses to major abdominal surgery only to a minor extent, although it may attenuate the haemodynamic response.


Asunto(s)
Anestesia Epidural , Anestesia General , Colecistectomía , Activación Plaquetaria , Estrés Fisiológico/sangre , Adenosina Difosfato/farmacología , Adulto , Anciano , Glucemia/análisis , Plaquetas/metabolismo , Presión Sanguínea , Colecistectomía/efectos adversos , AMP Cíclico/sangre , Femenino , Frecuencia Cardíaca , Humanos , Hidrocortisona/sangre , Persona de Mediana Edad , Agregación Plaquetaria/efectos de los fármacos , Serotonina/sangre , Estrés Fisiológico/etiología , Estrés Fisiológico/fisiopatología , beta-Tromboglobulina/análisis
19.
FEMS Microbiol Lett ; 123(1-2): 33-6, 1994 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-7988895

RESUMEN

Cell multiplication and growth of Saccharomyces cerevisiae were followed in 2-ml test tubes containing Wickerham's synthetic medium or very dilute synthetic media supplemented in various ways. The ability of the cell cultures to leave the lag phase and enter the exponential phase of growth was investigated. Multiplication was assessed by microscopical observation. The results showed great differences in times required for the cultures to leave the lag phases and begin multiplication. In Wickerham's medium, all cultures grew well 6 h after inoculation. In the dilute medium, several days elapsed before all the cultures grew. These cultures went into exponential growth with approximately first order kinetics. In the unsupplemented medium, the 'half-lives' in the lag phase were about 28 h. Addition of either Ca2+ or Ca2+ plus A23187 (calcimycin) reduced the half-lives to 10 and 6 h, respectively. The doubling times in the exponential phases of growth were not shortened by these additions. We suggest that Ca2+ plays a crucial role as a signal to switch on the mode of cell proliferation in S. cerevisiae.


Asunto(s)
Calcio/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/crecimiento & desarrollo , Calcimicina/farmacología , Medios de Cultivo
20.
Eur J Anaesthesiol ; 11(3): 169-73, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-8050421

RESUMEN

In order to evaluate the impact of minor surgery on platelet aggregability and the effect of anaesthesia on this parameter, we allocated 14 otherwise healthy men for inguinal herniotomy to either general anaesthesia (n = 7) or lumbar epidural anaesthesia (n = 7). Platelet aggregation threshold to adenosine diphosphate (ADP-threshold) was measured before and after anaesthesia, prior to surgery, at the end of surgery and during the following hours as well as on the first post-operative morning. General anaesthesia did not affect ADP-threshold while epidural analgesia itself induced a significant increase. During and soon after surgery the ADP-threshold increased in those receiving general anaesthesia while in those receiving epidural analgesia the ADP-threshold returned to pre-operative levels. On the first post-operative morning both groups showed a significantly lower ADP-threshold as compared to the pre-operative level. Surgery induced an increase in 3'5' cyclic-adenosine monophosphate (cAMP). This adrenergic response was attenuated by epidural analgesia.


Asunto(s)
Anestesia Epidural , Anestesia Intravenosa , Hernia Inguinal/cirugía , Agregación Plaquetaria , Adenosina Difosfato/farmacología , Adolescente , Adulto , Anciano , Bupivacaína , AMP Cíclico/sangre , Droperidol , Volumen de Eritrocitos/efectos de los fármacos , Fentanilo , Humanos , Hidrocortisona/sangre , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Menores , Agregación Plaquetaria/efectos de los fármacos , Agregación Plaquetaria/fisiología , Recuento de Plaquetas/efectos de los fármacos , Estrés Fisiológico/sangre , Estrés Fisiológico/fisiopatología , Tiopental
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA